KBC Group
NTUS

KBC Group’s Natus Medical Inc NTUS Stock Holding History

KBC Group’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,883
Closed -$94K – 1585
2022
Q2 		$94K Buy
+2,883
New +$91.1K ﹤0.01% 1248
2019
Q2 		– Sell
-3,526
Closed -$89K – 1497
2019
Q1 		$89K Buy
+3,526
New +$105K ﹤0.01% 1283
2018
Q3 		– Sell
-22,173
Closed -$765K – 1421
2018
Q2 		$765K Hold
22,173
– – 0.01% 889
2018
Q1 		$746K Buy
+22,173
New +$702K 0.01% 865
2015
Q1 		– Sell
-6,342
Closed -$229K – 1435
2014
Q4 		$229K Hold
6,342
– – ﹤0.01% 1162
2014
Q3 		$187K Buy
6,342
+2,817
+80% +$77.7K 0.01% 1000
2014
Q2 		$89K Hold
3,525
– – ﹤0.01% 1219
2014
Q1 		$91K Sell
3,525
-2,562
-42% -$64.6K ﹤0.01% 1149
2013
Q4 		$137K Buy
+6,087
New +$118K ﹤0.01% 1085

Other funds holding NTUS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

KBC Group's NTUS Position: Q3 2022 in Review

KBC Group sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 2,883 shares — an estimated $94K sold.

KBC Group first reported a position in NTUS in Q4 2013 and held it in 9 quarters. The position peaked at $765K in Q2 2018. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.

  • KBC Group reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
  • KBC Group sold 2,883 Natus Medical Inc shares in Q3 2022, an estimated $94K.
  • KBC Group first reported a position in Natus Medical Inc in Q4 2013 and held it in 9 quarters.
  • KBC Group's Natus Medical Inc position peaked at $765K in Q2 2018.
  • 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.

Based on KBC Group's 13F filing for Q3 2022, filed 8 Nov 2022.